Re-Engineering Basic and Clinical Research to Catalyze Translational Nanoscience

具体目标是：-为未来的转化纳米医学建立优先级，并刺激研究，从而纳米技术和纳米科学范式将促进药物输送，药物和治疗开发，体内成像，体外诊断，活性植入和组织修复/再生。-包括来自学术界和工业界的杰出科学家和工程师组成的多学科小组，他们在材料、生物和物理科学领域工作，致力于纳米器件和纳米技术的发展，以及来自美国国立卫生研究院和霍华德休斯医学研究所支持的转化研究项目的有远见的临床研究人员，他们在基因组学、蛋白质组学、多器官系统、与人类常见疾病有关的分子和途径。-激发独特的变革性，新颖和综合策略，以促进临床实践的应用。这包括加速纳米级技术的发展，使细胞和亚细胞生理学的体内探针成为可能。

The specific objectives are to:-Establish priorities for future translational nanomedicine and stimulate research, whereby nanotechnologies and nanoscience paradigms will facilitate drug delivery, drug and therapeutic development, in vivo imaging, in vitro diagnostics, active implants and tissue repair/regeneration.-Include as speakers a multidisciplinary group of outstanding scientists and engineers from academia and industry working in the materials, biological and physical science disciplines toward the development of nanodevices and nanotechnologies, together with visionary clinicalresearchers from translational research programs supported by NIH and the Howard Hughes Medical Institute who have expertise in genomics, proteomics, multiple organ systems, molecules and pathways implicated in common human diseases.- Stimulate uniquely transformative, novel, and integrative strategies to catalyze the application to clinical practice of. This includes acceleration of the development of nanoscale techniques that enable in vivo probes of cellular and subcellular physiology.